109769 ⎘
dsDNA viruses; Details; Herpesviridae; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Compositions and Methods for Delivering CFTR Polypeptides
#2Modified Herpes Simplex Virus Type 1
#3Larygotracheitis Virus (LT) Vector Vaccines for use with Avian Respiratory Pathogens
#4RECOMBINANT HERPESVIRUS OF TURKEY VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF
#5Recombinant Adeno-Associated Vectors For Targeted Treatment
#6METHODS OF ENHANCING DIVERSITY OF HLA HAPLOTYPE EXPRESSION IN TUMORS TO BROADEN TUMOR CELL SUSCEPTIBILITY TO TCR-T THERAPY
#7Oncolytic virus vector and application thereof
#8RECOMBINANT HVT AND USES THEREOF
#9COMPOSITIONS AND METHODS TO MANUFACTURE TUMOR SUPPRESSOR FUSIONS
#10RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF
#11PREFUSION-STABILIZED HERPESVIRUS GLYCOPROTEIN-B
#12MULTIVALENT HVT VECTOR VACCINE
#13Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
#14COMPOSITIONS AND METHODS TO MANUFACTURE TUMOR SUPPRESSOR FUSIONS
#15VACCINATION USING HERPESVIRUS GENOMES IN NUCLEIC ACID FORM
#16COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES
#17Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
#18COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES
#19Recombinant adeno-associated vectors for targeted treatment
#20Compositions and methods for delivering CFTR polypeptides
#21EHV with inactivated UL18 and/or UL8
#22METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION
#23Compositions and methods for generating reversion free attenuated and/or replication incompetent vaccine vectors
#24Oncolytic expression vector comprising a nucleic acid comprising a nucleotide sequence encoding GADD34
#25Combined use of a vector encoding a modified receptor and its exogenous agonist in the treatment of seizures
#26Recombinant adeno-associated vectors for targeted treatment
#27Swine influenza vaccine
#28Recombinant adeno-associated vectors for targeted treatment
#29Recombinant adeno-associated vectors for targeted treatment
#30Koi herpesvirus vaccine
#31Combined use of a vector encoding a modified receptor and its exogenous agonist in the treatment of seizures
#32Acceleration of vector virus induced immune response in avians
#33Method for augmenting vision in persons suffering from photoreceptor cell degeneration
#34Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof
#35ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISMS INCLUDING LACTIC ACID BACTERIAL STRAINS
#36Compositions and Methods for Enhancing Antigen-Specific Immune Responses
#37Vector
#38RECOMBINANT KOI HERPESVIRUS (KHV) OR CYPRINID HERPESVIRUS 3 (CYHV-3) AND A VACCINE FOR THE PREVENTION OF A DISEASE CAUSED BY KHV/CYHV-3 IN CYPRINUS CARPIO CARPIO OR CYPRINUS CARPIO KOI
#39Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof
#40Modulation of Mu Delta Opioid Receptor Expression
#41HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination
#42Recombinant infectious laryngotracheitis virus and uses thereof
#43Recombinant infectious laryngotracheitis virus and uses thereof
#44Recombinant herpesvirus and uses thereof
#45Recombinant infectious laryngotracheitis virus and uses thereof
#46Method for augmenting vision in persons suffering from photoreceptor cell degeneration
#47Oncolytic HSV1 vectors and methods of using the same